|
Volumn 180, Issue 6 I, 1999, Pages 1543-1550
|
Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk?
a a a a a a a a a a a |
Author keywords
Labor induction; Misoprostol
|
Indexed keywords
MISOPROSTOL;
PROSTAGLANDIN E2;
ADULT;
BRADYCARDIA;
CESAREAN SECTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FETUS DISTRESS;
HUMAN;
INCIDENCE;
INTRAVAGINAL DRUG ADMINISTRATION;
LABOR INDUCTION;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
|
EID: 0032978636
PISSN: 00029378
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9378(99)70050-5 Document Type: Conference Paper |
Times cited : (66)
|
References (13)
|